TipHub

412.6

-17.86 -4.15%

As of 16 Sept 2026 · delayed

NSE Listed

Gujarat Themis Biosyn Ltd. (GUJTHEM)

Volume: 3,94,301Avg Vol 1W: 7,06,085.6Avg Vol 1M: 7,78,577.452W Range:225.05479
Key Ratios
Checked 1h ago
Market Cap₹5,370 Cr
Current Price₹412.6
Previous Close₹430.46
High / Low (52w)₹479 / ₹225.05
Volume3,94,301
Avg Vol (1W)7,06,085.6
Avg Vol (1M)7,78,577.4
Stock P/E114.93
Book Value₹58.18
Dividend Yield14%
ROE
ROA0%
Revenue (TTM)₹168 Cr
Revenue Growth22.1%
Profit Margin25.04%
Total Debt₹162 Cr
Shares Outstanding13 Cr
Face Value₹1
EPS (TTM)₹3.59
P/B7.09
Debt / Equity0.36
50 DMA₹382.94
200 DMA₹361.04
Day change-4.15%
Price Chart
412.6 7.02% · 1Y
47022796.6L
2025-09-17
2026-09-16

20-day avg volume: 7.8L shares

Pros
  • Pays a dividend yield of 14.0%.
  • Company is almost debt-free.
Cons
  • Revenue fell 50% YoY.
  • Stock trades at a high P/E of 115.
Quarterly Results
MetricMar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Mar 2026Jun 2026
Revenue₹42 Cr₹39 Cr₹35 Cr₹40 Cr₹38 Cr₹36 Cr₹44 Cr₹44 Cr
EBITDA₹21 Cr₹18 Cr₹14 Cr₹18 Cr₹15 Cr₹12 Cr₹16 Cr₹17 Cr
Net Profit₹16 Cr₹13 Cr₹11 Cr₹13 Cr₹12 Cr₹9 Cr₹11 Cr₹11 Cr
EPS1.1
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹38 Cr₹152 Cr₹36 Cr₹42 Cr₹43 Cr₹168 Cr₹44 Cr₹44 Cr
EBITDA₹16 Cr₹66 Cr₹12 Cr₹19 Cr₹18 Cr₹65 Cr₹16 Cr₹17 Cr
Net Profit₹12 Cr₹49 Cr₹9 Cr₹14 Cr₹12 Cr₹47 Cr₹11 Cr₹11 Cr
EPS4.484.28
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹33 Cr₹64 Cr₹88 Cr₹123 Cr₹166 Cr₹221 Cr₹301 Cr₹503 Cr
Total Liabilities₹14 Cr₹22 Cr₹18 Cr₹19 Cr₹17 Cr₹20 Cr₹53 Cr₹216 Cr
Equity₹19 Cr₹42 Cr₹70 Cr₹103 Cr₹149 Cr₹201 Cr₹248 Cr₹288 Cr
Total Debt
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹8 Cr₹21 Cr₹55 Cr₹60 Cr₹84 Cr₹108 Cr₹59 Cr
Investing₹-3 Cr₹-2 Cr₹-30 Cr₹-20 Cr₹-55 Cr₹-112 Cr₹-172 Cr
Financing₹2 Cr₹-5 Cr₹-14 Cr₹-13 Cr₹-9 Cr₹26 Cr₹115 Cr
Free Cash Flow₹8 Cr₹21 Cr₹55 Cr₹60 Cr₹84 Cr₹108 Cr₹59 Cr
Shareholding
Promoter 59.33% Institutions 18.72% Public 21.95%
About Gujarat Themis Biosyn Ltd.

Healthcare · Drug Manufacturers - Specialty & Generic

Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals and medicinal chemicals in India and Japan. The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease; Rifamycin-O for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy; and Lovastatin. The company was incorporated in 1981 and is based in Mumbai, India.

www.gtbl.in
Efficiency & Working Capital
ROCE27.2%
Interest Coverage17.2
Dividend Payout
Debtor Days134 d
Inventory Days34 d
Payable Days81 d
Cash Conversion Cycle87 d
Working Capital Days168 d
Shareholding Details

As of 2026-08-31

Promoter59.3%
FII4.9%
DII13.8%
Institutions18.7%
Public21.9%
Promoter Pledge0%
No. of Shareholders26,899
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodMar 2024Jun 2024Sept 2024Dec 2024Feb 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Aug 2026
Promoters70.9%70.9%70.9%70.9%70.9%70.9%70.9%70.9%70.9%70.9%70.9%59.3%
FIIs1%1.4%1.5%1.4%1.5%1.9%2.5%3%2%1.8%1.8%4.9%
DIIs0.8%1.2%1.2%1.2%1.2%1.2%1.2%1.2%1.2%1.2%1.2%13.8%
Public27.3%26.5%26.5%26.5%26.5%26%25.5%25%26%26.2%26.2%21.9%
Promoter Pledge3.3%3.3%3.3%3.3%3.3%3.3%3.3%3.3%4.5%5.4%68.5%0%
No. of Shareholders29,57630,28031,27130,93430,43630,67328,94528,31927,32526,88627,01026,899
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603
Major Shareholders (>1%)
NameCategoryStakeShares
Pharmaceutical Business Group [india] LtdShareholding of Promoter and Promoter Group39%5.07 Cr
Themis Medicare LimitedShareholding of Promoter and Promoter Group17.5%2.28 Cr
Quant Mutual Fund - Quant Small Cap FundPublic Shareholding7.5%97,28,577
Ayushmat LtdPublic Shareholding2.8%36,21,130
Sachin Dinesh PatelShareholding of Promoter and Promoter Group2.3%30,20,760
Kotak Mahindra Life Insurance Company Ltd.Public Shareholding2.2%28,24,859
Bank Of India Small Cap FundPublic Shareholding1.6%21,18,645
Capri Global Capital LimitedPublic Shareholding1.1%14,12,430
Dinesh S PatelShareholding of Promoter and Promoter Group0.5%6,60,297
Anay Rupen ChoksiShareholding of Promoter and Promoter Group0%22,852
Nysha Rupen ChoksiShareholding of Promoter and Promoter Group0%22,852
Dinesh Shantilal PatelShareholding of Promoter and Promoter Group0%15
Jayshree D PatelShareholding of Promoter and Promoter Group0%10
Reena S PatelShareholding of Promoter and Promoter Group0%10
Board of Directors
NameDesignationYear
Dinesh S PatelChairman & Non Executive Dir.2025
Sachin D PatelManaging Director2025
Kirandeep MadanIndependent Non Exe. Director2025
Hitesh Dharmasinh GajariaIndependent Non Exe. Director2025
K G AnanthakrishnanIndependent Non Exe. Director2025
NIHAR AJAY PARIKHIndependent Director2025
Rajneesh AnandAdditional Director2025
Segments — Product
SegmentRevenueShare
Bulk Drugs for its own & Job Work₹0 Cr
Segments — Geography
RegionRevenueShare
India₹166 Cr100%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹1251111
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-07Board Meetings
dividend2025-09-04₹0.67 (67%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000213
2025000011
2025000202
Insider / Designated-Person Trades

7 recent disclosure(s)

Pharmaceutical Business Group [India] LtdDisposal · 30,00,000
Mrs.Avantika Vijay AgarwalAcquisition · 5,400
Mrs.Avantika Vijay AgarwalDisposal · 3,704
Ms. Avantika Vijay AgarwalDisposal · 656
Ms. Avantika Vijay AgarwalDisposal · 9,032
Pharmaceutical Business Group India LimitedAcquisition · 38,50,000
Substantial Acquisitions (SAST)

2 disclosure(s)

NULL08/07/2026 - 14/07/2026 · 5,25,000
NULL30/06/2026 - 03/07/2026 · 26,00,000
Company Information
Incorporated1981
ChairmanDinesh S Patel
AuditorGMJ & Co
🌐 www.gtbl.in

📍 69/C GIDC Industrial Estate, Valsad Dist, VAPI, Gujarat, 396195

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search